InMed Pharmaceuticals Inc
INM
$1.32-0.75%
End of day · as of Oct 16, 2026, 8:30 PM ET
Mkt cap
$5.24M
EV/Sales
-1.18
P/E ratio
N/A
FY2025 Revenue
$4.94M
EPS (TTM)
$-8.45
Gross Margin (FY2025)
34.53%
Profit Margin (FY2025)
-165.14%
Beta
0.97
Div yield
N/A
Sector
Healthcare
InMed Pharmaceuticals Inc (INM) is a drug manufacturers - specialty & generic company listed on US.
Latest reported INM revenue for 2025-06-30 was $4.9M. Net income was -$8.2M. Revenue was up 7.5% from 2024-06-30 to 2025-06-30. INM currently screens at market cap $5.2M.
Use this INM research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full INM income, balance, and cash tables.
InMed Pharmaceuticals Inc (INM) is a drug manufacturers - specialty & generic company in the Healthcare sector.
Latest cached InMed Pharmaceuticals Inc (INM) revenue for Jun 30, 2025 was $4.9M. Net income was -$8.2M. Statements: https://lician.com/financials/inm
InMed Pharmaceuticals Inc (INM) market capitalization is $5.2M on the latest cached snapshot.
InMed Pharmaceuticals Inc (INM) cached previous close $1.33; day range $1.32 – $1.32; volume 4,280. Session quote: https://lician.com/quote/inm
InMed Pharmaceuticals Inc (INM) latest cached earnings event is "INM earnings" on Sep 28, 2026. Earnings calendar: https://lician.com/earnings
The latest cached INM filing is 8-K · Sep 18, 2026. Filings: https://lician.com/sec/inm